Select your language![[img] English](/images/pediculosis/system/flag-gb.jpg)
![[img] Français](/images/pediculosis/system/flag-fr.jpg)
![[img] Deutsch](/images/pediculosis/system/flag-de.jpg)
![[img] Español](/images/pediculosis/system/flag-es.jpg)
![[img] Nederlands](/images/pediculosis/system/flag-nl.jpg)
Eden Research Licence Agreement
Eden Research has announced an agreement with Neo-Pharma Innovations to develop their terpene-based head lice treatment for commercial sale.
The agreement, announced on June 05, grants Neo-Pharma a 20-year licence to the intellectual property rights to the treatment, allowing them to seek regulatory approval, manufacture and sell the product globally.